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INTRODUCTION

The earliest recognition in the medical
characterized by cirrhosis,
a

diabetes mellitus,

lecture on diabetes by Trousseau in 1865

1889

coined the name now most commonly used

hemochromatosis

(2).

literature of a syndrome

More recently,

(1).

and melanoderma was in
Von Recklinghausen in

to designate this entity:

Sheldon published in 1935 a mono¬

graph which provided a comprehensive review of

the clinical,

and investigative experience with hemochromatosis.

pathologic,

This work,

by suggest¬

ing that the disease represented an inborn error of metabolism,
petus to the further
factors

gave im¬

study of possible genetic and metabolic pathogenic

(3).

Despite the length of
and studied,

time that hemochromatosis has been recognized

a theory generally accepted as explaining satisfactorily

its etiology and pathogenesis has thus far not been evolved.

As indi¬

cated by the context in which Trousseau first mentioned hemochromatosis,
the earliest students of
variant of diabetes

(4).

sequently suggested,

the disease considered it simply an interesting
Many other etiologic possibilities were sub¬

but most present-day theories have been derived

from the concept of Sheldon that the primary abnormality is an inborn
error of iron metabolism

(3).

According to workers following Sheldon,

this metabolic error causes an enormously increased absorption of iron
through the intestinal mucosa

(5).

These concepts have been included in

two of the most recent theories, which differ,
attributed to

however,

the ultimate accumulation of iron in the

and Finch consider

in the importance
tissues.

the manifestations of hemochromatosis as results of the

tissue damage produced directly by cellular iron loading
to Dubin,

however,

Finch

(6).

According

the same metabolic error causes both increased iron

N.
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absorption and,

independently,

fibrosis of

the

ing in the clinical features of hemochromatosis

liver and pancreas result¬
(7).

The close association of portal cirrhosis with hemochromatosis has
long been recognized

(3).

Some writers have considered portal cirrhosis

the sole cause of hemochromatosis, which they regard as a variant of this
type of cirrhosis,
of

but most authors merely have mentioned the similarity

the histopathology in the two diseases and the high incidence of

’’harmless" tissue iron in typical portal cirrhosis

(3,8,12).

The present retrospective clinico-pathologic study was proposed to
investigate further the relationship of portal cirrhosis to hemochromatosis,
hoping ultimately to understand better
and pathogenesis.

the nature of

the

latter's etiology

Specific areas to be explored in reference to patients

with portal cirrhosis were:

(1)

the incidence of stainable parenchymal

and reticuloendothelial hepatic iron,

(2)

the relation of

the degree of

hepatic siderosis to hepatic structural and functional damage,
correlation of the incidence of pancreatic with hepatic iron,
relation of pancreatic iron to pancreatic fibrosis,
of

and

(5)

(3)
(4)

the
the

the correlation

the incidence of splenic with hepatic iron.

MATERIALS AND METHODS

Case Selection and Pathologic Studies
All cases with a primary or
"hepatic fibrosis" or
the years
Pathology.

subsidiary post-mortem diagnosis of

"cirrhosis" at the Yale-New Haven Medical Center in

1952-1959 were selected from the files of the Department of
From the

130 cases

made of formalin-fixed

liver,

thus obtained microscopic sections were
pancreas,

and spleen.

Liver

sections were

-3-

prepared with Masson's trichrome

stain;

sections from all

three organs

were stained for iron (hemosiderin) with the Hubbell modification of the
Gomori

technique,

using 2% hydrochloric acid and 2% potassium ferrocyanide

(9).
Liver sections from all cases were examined microscopically to sub¬
stantiate the diagnosis of cirrhosis;
and were separated into two major
(Laennec's)
cardiac,

cases remained in this category

groups:

60 cases with typical portal

cirrhosis and 28 with other specific

and biliary)

fibrosis,

88

types

or unclassified cirrhosis.

small isolated regenerative nodules

(post-necrotic,

Diffuse monolobular

(pseudolobules),

parenchymal degeneration in the form of alcoholic hyaline
and fatty hepatocellular changes,

(Mallory bodies"),

in the absence of congestive or bile

duct alterations specific for cardiac or biliary cirrhosis,
the basis for

active

constituted

the morphologic diagnosis of portal cirrhosis.

In addition,

a positive history of alcoholism was considered in evaluation of type of
cirrhosis.
Semiquantitative grading of hepatic iron content was established with
emphasis on hepatocellular rather
iron.

than reticuloendothelial

(Kupffer cell)

Cases without hepatocellular iron were divided into those with no

stainable

liver iron and those with only Kupffer cell iron;

hepatocellular iron were graded from 1+ to 4+,
Kupffer cell iron being disregarded.
cases with 1+ and 2+ hepatocellular

the amount of

In the final

cases with
coincident

tabulation of results,

iron were grouped as "slight," those

with 3+ and 4+ as "marked."
The extent of hepatic fibrosis was assessed by separating all cases
into two groups:
fibrosis."

those with "moderate fibrosis" and those with "advanced

Hepatocellular fat content was graded from 1+ to 4+.

In the

-4-

final tabulation all cases having only a trace (1+) of fat were not included
in the "significant fat" category. Marked involvement of hepatic parenchymal
cells with clearcut alcoholic hyaline ("Mallory bodies") was noted.

Also

noted were liver sections containing typical "glycogen nuclei" (the
nuclei appearing to contain single large empty vacuoles)

(11).

Stromal and parenchymal pancreatic iron content was assessed in a
manner similar to that for hepatic iron and ranged from trace (1+) to mild
(2+), excepting one case with moderate iron staining in a non-portal
cirrhotic patient.
"absent."

Siderosis was tabulated only as being "present" or

The location of the iron, whether in fibrous,

acinar or islet

tissue, was noted but not included in the final tabulation.
Ferrocyanide-stained sections of pancreas could not be evaluated for
fibrosis;

instead,

these data were obtained from the complete autopsy pro¬

tocols.
The ferrocyanide-stained sections of spleen were evaluated for both
the amount

(from 1+ to 4+) and the

were tabulated as

location of iron.

"slight," 3+ and 4+ as

1+ and 2+ iron

,5marked."

Clinical Studies
For the sixty patients with portal cirrhosis data regarding age,
and race were available.
only 52 patients;
Few charts were

However,

sex

hospital charts could be obtained for

the clinical data are based on the records of this group.

satisfactorily complete; many items in the history and

physical examination were not mentioned and for some patients there were
few laboratory data.

The 55 white patients were considered separately by sex and by age
relative to the median age for their sex.

The median age proved to be 57

-5-

years for men and 49 years for women.

The five Negro patients were con¬

sidered individually.
All but two of the patients who admitted to excessive alcoholic in¬
take placed its duration at more than five years.
had drunk heavily for
alcoholics.

The other two patients

less than one year and were not included as chronic

Dietary habits were poorly documented in the records;

mention of several years'

specific

inadequate diet by the patient was a requisite

for his inclusion in the "poor diet" category.
Patients with a history of either ankle edema
cardiac disease)

or ascites were

(even those with known

listed as having "fluid retention."

Those with a history of hematemesis or melena were included in the category
of "GI bleeding."

Clearcut symptoms and signs of cardiac failure or a

definite diagnosis of congestive heart failure was accepted for inclusion
of a patient in this category.

Conversely,

only those patients with a

well-established diagnosis of diabetes mellitus were considered as having
the disease.
On the basis of physical examination patients were categorized as hav¬
ing "bronze pigmentation" whenever

it was noted as present or doubtful.

For inclusion of a patient in the group with "jaundice," however,
icterus had to be definite.
livers felt to be 4 cm.

"Hepatomegaly" included all

(two fingerbreadths)

his

those cases with

or more enlarged.

Ascites and

edema, whatever the presumed cause, were considered as indicating "fluid re¬
tention."

Patients were included in the "abnormal heart" grouping if

exhibited cardiomegaly,

significant murmurs,

or cardiac failure.

they

Testi¬

cular atrophy, when described in the hospital record, was noted.
Admission hematocrits were available on almost all patients with hos¬
pital charts; values under 30% (9

gm.70 hemoglobin) were considered as indi-

..
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cating anemia.

Serum iron determinations were available on only three

patients and were so listed.

Patients with elevated fasting blood sugars

(more than 100 mg.%) or glycosuria

(including a

their hospital stay were carefully screened;

trace of glucose)

during

those receiving intravenous

infusions were not included in these tabulations.
Patients receiving transfusions were given from 1
blood;

to 53 pints of

they were listed simply as having been "transfused."

Patients

with the clinical picture of congestive heart failure at any time during
their hospital course were so

listed.

Those patients with advanced liver

disease, mental obtundation and asterixis were considered to have
coma."

Finally,

melena

"hepatic

patients with hematemesis, massive rectal bleeding or

(as demonstrated by the guaiac

test) were considered together in

the group "GI bleeding."
These detailed clinical features were not studied in
of non-portal

the 28

cases

cirrhosis.

RESULTS

Table

l
The incidence of the various histologic characteristics studied in

the liver,

pancreas,

and spleen in cases of portal cirrhosis are correlated

with the extent of hepatic siderosis in Table 1.

It is seen that 657, of

the patients with portal cirrhosis exhibited stainable iron in the

liver,

42% having hepatocellular iron and 237, having iron solely in the Kupffer
cells.

As

stated before, many of

the livers containing hepatocellular

iron also contained Kupffer cell iron.

However,

amount of reticuloendothelial iron as compared to

in a given case,

the

the amount of parenchymal

7

-

iron was typically slight;

-

in many liver sections with mild to moderate

hepatocellular siderosis no Kupffer cell iron could be found.
The extent of hepatic fibrosis apparently correlated with the ex¬
tent of hepatocellular siderosis,

the incidence of advanced fibrosis being

407, in cases without hepatocellular iron, 507, in those with slight hep¬
atocellular iron, and 717, in cases with marked hepatocellular iron.
contrast,

In

there was no relation between the incidence of Kupffer cell

siderosis and the incidence of advanced fibrosis,

the latter condition

occurring in 36% of cases with only Kupffer cell iron and in 43% of those
with no hepatic iron.
In evaluating the extent of hepatocellular fat, it seemed that the
fat content varied inversely as the extent of fibrosis.

This impression

was strengthened by the low incidence (29%) of fat in cases with marked
hepatocellular iron as compared to those without hepatocellular iron (707,).
The significance of the high (83%) correlation of fat with slight hepato¬
cellular siderosis is unclear.

Fatty hepatocellular changes appeared about

equally frequent in the livers with only Kupffer cell iron (647,) and in
those without (7670).
No alcoholic hyaline was found in livers with hepatocellular iron.
However,

the incidence of these cytoplasmic changes was not significantly

decreased in cases with only Kupffer cell iron (21%) as compared to those
with no liver iron (247o).
The incidence of "glycogen nuclei" was greatly increased in the pres¬
ence of hepatocellular siderosis.

These nuclear changes occurred in 57,

of cases with no hepatocellular iron, in 17% of those with slight and
43% of cases with marked hepatocellular iron.
There was a strong correlation between the presence of hepatocellular
and pancreatic siderosis.

In none of the 14 cases with only Kupffer cell

8-

-

iron and in one of the 21 with no hepatic iron was pancreatic iron encoun¬
tered.

This was in contrast to

patients with slight

the frequency of pancreatic siderosis in

(407.) and marked

(67%) hepatocellular siderosis,

extent of pancreatic siderosis was never great,

the amount of iron in the

most severely affected pancreas corresponding roughly to 2+ (mild)
involvement.
however,
est,

The

The location of the iron was inconstant,

being more affected than the fibrous tissue.

hepatic

the acinar tissue,
Of especial inter¬

the islets were rarely and minimally involved.
The incidence of pancreatic fibrosis seemed not to be related to

the

extent of hepatocellular siderosis and was actually less in the patients
with Kupffer cell iron
Of
in 40%,

(12%)

than in those with no hepatic iron

(64%).

the 21 cases with no hepatic iron,

splenic siderosis was absent

slight in 50%, and marked in 107,.

In the groups with only Kupffer

cell iron and with slight hepatocellular iron, which were identical re¬
garding frequency and extent of
iron were much less frequent

splenic siderosis,

(770).

This

cases without splenic

lower incidence was associated

with a greater incidence of slight splenic siderosis
siderosis remained uncommon (147,).

(78%); marked splenic

The six cases of marked hepatocellular

siderosis were associated with a striking increase in splenic iron.
one case

there was no splenic iron;

in two there was

marked splenic involvement with iron.
the pancreas,
ity.

In contrast to

and in three,

the situation in

the location of the iron in the spleen showed great uniform¬

In all cases

the white pulp

slight.,

In

the hemosiderin deposits were restricted to the red pulp--

(Malpighian corpuscles),

blood vessels,

and trabeculae being

spared.

Table 2
The clinical and pathologic pancreatic abnormalities investigated are
correlated with the occurrence of pancreatic iron in Table 2.

(

V.
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-

There was neither historical nor clinical evidence of diabetes mellitus in the 9 patients with pancreatic siderosis in contrast to the posi¬
tive family histories and clinical indications of diabetes in several of
the 31 patients without pancreatic siderosis»
three

(43%)

Pathologically,

however,

of the seven cases of pancreatic siderosis for which post-mor¬

tem protocols were available were reported as having slight to marked pan¬
creatic fibrosis.

This contrasts with the lower incidence

creatic fibrosis in cases without siderosis.

Of interest,

(24%)

of pan¬

the frequency

of pancreatic siderosis had no effect on the frequency of hepatic "glycogen
nuclei."

Table 3
Table 3 summarized the relation of many clinical aspects of portal
cirrhosis and hemochromatosis

to the incidence and extent of hepatic

and pancreatic siderosis in 60 patients with portal cirrhosis.
This sample was comprised of 55 white and 5 Negro patients--32 men and
28 women.

The median age in years for white men was 57;

For white women the median age was 49 years,
difference in mean ages between the
to be statistically significant,

two sexes

the mean was 58.6.

the mean being 52.7.
(5.9 years)

The

did not prove

although it is probable that if the older

age for women in the general population were taken into consideration
this difference of 5.9 years would attain statistical significance.

The

cases with little or no hepatocellular iron were fairly evenly distributed
among the sex and age groups.
evident,

however,

Both male and old age predominance became

in the cases with marked hepatocellular siderosis.

The incidence of patients with a prolonged excessive alcoholic intake
was uniformly high in all categories of hepatic iron deposition.

The pres¬

ence of parenchymal iron was associated with an incidence of poor diet
(777o) higher than that for cases with no

liver iron

(507o) or with only

o

(. - •

■

'

v.

5.
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Kupffer cell

iron (167,).

The frequency of a history of fluid retention correlated slightly
with the incidence of iron in either parenchymal or reticuloendothelial
cells.
507,;
iron,

In cases with no hepatic iron the incidence of fluid retention was

in those with only Kupffer cell iron,
697,;

677,;

and with marked hepatocellular iron,

with slight hepatocellular
837>.

Jaundice on physical examination was noted more frequently in patients
with parenchymal
cell iron,

siderosis,

being observed in 257, of cases with only Kupffer

in 507, of cases with no hepatic iron,

and in 867, of cases with

parenchymal iron.
Two of the three values for serum iron concentration

which were avail¬

able were on patients who were without hepatic or pancreatic siderosis.
determination was within the normal range

(70 meg.7,);

One

the other was elevated

(140 mcgoT,) but not in the range consistently seen in patients with idio¬
pathic hemochromatosis

(6).

The third serum iron concentration was

meg.7, and was determined in a patient with both

130

slight hepatocellular

and pancreatic siderosis.
There was no noteworthy correlation between variations in the inci¬
dence of the remaining clinical features

(Table 3)

and extent of hepatic and pancreatic siderosis.

and in the frequency

Such clinical features in¬

cluded:

personal history of gastrointestinal bleeding,

failure,

and diabetes;

and diabetes;

fluid retention,

ing.

cardiac disease,
hepatomegaly,

testicular atrophy, and cardiac abnor¬

laboratory data including low hematocrit,

sugar, and glycosuria;
therapy,

family history of hepatic disease,

evidence on physical examination of melanoderma,

palpable spleen,
mality;

congestive heart

elevated fasting blood

and a course in the hospital including transfusion

congestive heart failure,

hepatic coma,

and gastrointestinal bleed¬

-

:
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In summary:

in the sixty cases of portal cirrhosis the

tained stainable iron in 65% of
enchymal cells were involved.
splenic iron in 847. of

the cases;

in 437. of

the cases

the par¬

Pancreatic iron was found in 237. and

the forty cases in which microscopic sections of

these organs were available.

Pathologically,

the presence of hepato¬

cellular iron was associated with an increased incidence
that in cases without hepatocellular
pancreatic siderosis,

liver con¬

iron)

(as compared to

of hepatic "glycogen nuclei,"

and splenic siderosis; with an increased extent of

hepatic fibrosis and splenic siderosis;

and with a decreased incidence of

hepatocellular fatty change and alcoholic hyaline.

The presence of Kup-

ffer cell iron was correlated with an altered incidence of only one patho¬
logic parameter:

splenic siderosis.

Pancreatic siderosis was accompanied

by an increased frequency of pancreatic fibrosis.
features,

Regarding clinical

a correlation was apparent between the presence of marked hep¬

atocellular siderosis and increased incidence of advanced age, male sex,
histories of poor diet and fluid retention,

and jaundice on physical exam¬

ination.
By way of comparison,
in this

the 28

cases of non-portal

study are shown in Table 4.

necrotic cirrhosis,
cirrhosis;

cirrhosis encountered

There were nine patients with post¬

seven with cardiac cirrhosis,

and three with biliary

nine additional cases could not be morphologically diagnosed

with assurance and were

labeled "unclassified."

The incidence of stainable hepatic iron in post-necrotic cirrhosis
was comparable to

that in portal cirrhosis in regard to both total hepatic

(67%) and hepatocellular
sis

(44%)

(all with histories of

The cases of cardiac cirrho¬

long-standing hepatic congestion),

were remarkably free of hepatic
bited no hepatic iron,

iron content.

siderosis;

however,

five of the seven cases exhi¬

and only one had hepatocellular iron.

Two of

the

<%

.

.

-

..
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three cases of hiliary cirrhosis were without hepatic iron;

in the

third

there was slight hepatocellular iron.
Of the twelve pancreases
portal cirrhosis,

only three

studied in the cases of classified non¬
(one in each type of cirrhosis) were siderotic,

all three appearing in cases with ]ivers free of iron.
Eleven spleens in these same

types of cirrhosis were examined.

All

four of the spleens containing narked amounts of iron were associated with
Kupffer cell siderosis.

-

.
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DISCUSSION

Three major aspects of hemochromatosis will be discussed:
nition,

its pathogenesis,

its defi¬

and its relationship to portal cirrhosis,,

zing the observations made during this retrospective investigation,

Utili¬
these

general phases will be covered and the 5 more limited objectives of the
study emphasized,,
Definition or diagnostic criteria.
don's monograph in 1935,

However,

the publication of Shel¬

the basis for the diagnosis of hemochromatosis

was the clinical triad of cirrhosis,
tation (3)o

At the time of

diabetes mellitus and bronze pigmen¬

the frequent absence of one or more of

in pathologically-established cases,

these features

and the occasional concurrence of all

3 in patients with simple cirrhosis pointed up the necessity for more ex¬
act pathologic and chemical diagnostic parameters.
notably Finch and Finch

(6),

Many authors, most

have stressed the demonstration of hepatic

cirrhosis and hemosiderosis as being critical in definitive diagnosis.
When confronted with these features in atypical cases,

however,

sought confirmation in laboratory determinations such as

they have

serum iron content,

serum iron-binding protein saturation and bone marrow iron content.

Sim-

iliarly, Dubin (7) has advocated resolution of pathological uncertainty
by the use of iron tolerance tests.
Purely morphologic features have formed the basis of diagnosis in the
studies of Kleckner e£ al^ (12)
(13).

and, more recently,

MacDonald and Mallory

These latter investigators have formulated a rather rigid and re¬

stricting diagnostic tetrad,
hepatic parenchymal,
fibrosis;

including:

portal cirrhosis;

bile duct and stromal cells;

siderosis of

pancreatic siderosis and

and parenchymal siderosis in other organs.

Neither clinical nor

-14-

functional factors were considered vital in the diagnosis by these au¬
thors.
These conflicts seem to indicate that no set of criteria,
biochemical or morphologic,
hemosiderosis.
emma.

Thus,

definetfadequately the disease or

clinical,

syndrome of

The current study further emphasizes this diagnostic dil¬

over 407, of

these patients with well-established Laennec's

cirrhosis had abnormal liver cell iron content, many having hemosiderin
in Kupffer cells and stomal tissue as well.

Further,

two-thirds of

those

with hepatocellular siderosis had pancreatic siderosis, many having pan¬
creatic fibrosis and splenic hemosiderosis in addition.
therefore,

a spectrum of parenchymal iron-loading and tissue damage

manifested by fibrosis)
hosis;

Morphologically,

on the other is

exists.

On the one extreme is

(as

"pure" portal cirr¬

"typical" hemochromatosis, with hepatic and pancrea¬

tic siderosis and fibrosis.

Varying combinations of parenchymal and stomal

changes exist between these two extremes, making any current set of cri¬
teria appear arbitrary and inadequate.
cell and splenic hemosiderosis,
therapy,

The frequent occurrence of Kupffer

even in cases without transfusion or iron

seems to invalidate Dubin's concept

siderosis separates

(7)

that reticuloendothelial

"hemosiderosis" from "hemochromatosis."

observations have been well*summarized by Bell

(9).

Similar

Occasional demonstra¬

tion of hepatocellular iron and pancreatic changes in patients with non¬
portal cirrhosis

(Table 4)

further obscures

the previouslyfestablished

morphologic classifications.
Pathogenesis.

The morphologic points of departure for most theories of

the pathogenesis of hemochromatosis have been the parenchymal siderosis
and fibrosis of the

liver and pancreas.

Thus, various investigators

have sought to relate the obvious over-retention of iron,
of hemosiderin in liver and pancreatic cells,

the accumulation

and tissue damage as mani-

-

.

•*

i
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fested by cell

loss and connective tissue over-growth.

Cell damage induced by "excessive" deposits of iron-containing sub¬
stances has been regarded as
many workers.

the primary pathophysiologic phenomenon by

Although not original with him,

theory in his monograph,

in certain patients,

Indeed,

However,

popularized this

later investigations have con¬

the striking over-absorption of ingested iron

across the intestinal mucosal barrier
hypothesis.

(3)

suggesting that the initial overload stemmed from

an "internal error of metabolism."
firmed,

Sheldon

(14),

thereby validating Sheldon’s

despite prolonged and massive iron feeding

injection (13) in experimental animals,

Perhaps fur

ther refuting the iron-excess-cell damage etiologic concept is

iron deposition.

(^lallory bodies)

On the other hand,

fibrosis and siderosis and the

and

definite hepatic or pancreatic cell

damage and fibrosis have not been demonstrated with certainty.

here of no hepatic cell necrosis

(14)

the finding

in livers with heavy

the coincidence of advanced hepatic

less constant pancreatic siderosis and scarr¬

ing might be interpreted as evidence that iron had,
duced cell death and resultant fibrosis.

Certainly,

in the past,
however,

pro¬

the major

clinical manifestations of hepatic disease in these patients could be wellexplained by the many parenchymal and stomal changes

that were unaccom¬

panied by significant siderosis.
Structural and functional changes of the liver itself have been con¬
sidered by some as primary in the evolution of hemochromatosis.
this century,

Simmonds

portal cirrhosis,

(8)

and others

in some undefined manner,
cently,

Rather

iron overload,

described hemochromatosis as

(16)

(15)

Early in

simply a variant of

postulated that hepatic fibrosis induced,

abnormalities of iron metabolism.

emphasized the possible sequence of

More re¬

liver damage -

indicating that intestinal iron absorption was often ex¬

cessive in both Laennec's cirrhosis and idiopathic hemochromatosis.

Ani-

s

V'

-
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mal experiments reported by Goldberg and Smith
support to this concept,
(dietary,

(17)

have given strong

leading them to postulate that hepatic injury

toxic or unknown)

leads to both increased intestinal absorp¬

tion and tissue binding of iron, with resultant hemosiderosis.
current clinico-pathological survey,
present throughout.

Nonetheless,

liver disease was

In the

(by definition)

the impression was gained that various

degrees of hepatocellular and pancreatic parenchymal siderosis were simply
engrafted on the underlying cirrhotic process.
cirrhotic

In general,

livers contained the most parenchymal iron,

the most

but actively-de¬

generating cells did not seem unusually vulnerable to iron deposition.
Portal cirrhosis is known to be accompanied frequently by pancreatic
fibrosis

(18);

hence,

the pancreatic siderosis seen might well be secon¬

dary rather than primary.

The deposition of hemosiderin in the

creas and spleen of many of the cirrhotic patients would,
credence to the idea that hepatic disease,
activity,

at

liver,

it seems,

pan¬

lend

least in some phases of

promotes abnormal intestinal absorption of iron and deposition

of hemosiderin in tissue sites.

These observations do not establish

any definite relationship between the clinical and laboratory manifesta¬
tions characteristic of hemochromatosis and morphologic alterations in
the

liver and pancreas.

Portal Cirrhosis and Hemochromatosis.
deposition,

Morphologically,

aside from iron

there is no constant feature which distinguishes

of unquestionable hemochromatosis from non-pigmentary portal
cirrhosis.

(Laennec's)

Most observers have emphasized the rarity of alcoholic hyaline

(^Mallory body")

formation in hemochromatosis;

this series,

of the cases of hepatic siderosis had alcoholic hyaline,
this.

the cirrhosis

MacDonald and Mallory

(13)

and Klechner et al

in which none

tends to confirm

(12),

however, have

described characteristic alcoholic hyaline necrosis in otherwise typical

J.

.

d

--

LL,‘Jl

_.\o

n

t
<L ~

<1

\
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hemochromatosis.
portal cirrhosis
In addition,

as

Pancreatic fibrosis occurs frequently in uncomplicated
(18)

and can not be considered unique to hemochromatosis.

shown in this study,

simple portal cirrhosis.

Thus,

pancreatic siderosis may be present in

there is no clear morphologic separation

between pigmented and non-pigmented portal cirrhosis.
Clinically,

patients with portal cirrhosis and marked hepatic siderosis

were set apart in several ways from those with portal cirrhosis alone.
Histories of poor diet and fluid retention and physical evidence of jaun¬
dice were slightly more common in the former group.
was the definite predominance of males
cellular siderosis.
cirrhosis,
(19,20),

Thus,

(6/7)

More striking,

however,

in the cases of marked hepato¬

these cases seem a connecting link between portal

in which roughly equal numbers of males and females are affected

and hemochromatosis,

have been males

(6,12).

in which about 90% of reported patients

Otherwise,

all the clinical manifestations con¬

sidered characteristic of hemochromatosis

(cirrhosis,

diabetes,

skin pig-

are
mentation, heart disease)^also present in uncomplicated portal cirrhosis

(9).

SUMMARY
In

retrospective studi^# of 60 post-mortem cases of portal cirrhosis

abnormal parenchymal hepatic iron was present in 43%.
cent of the cases studied had pancreatic siderosis,
with fibrosis,

and 84% had splenic siderosis.

Twenty-three per

frequently associated

Morphologically,

hepatocellular

iron was associated with striking hepatic fibrosis and pancreatic and splenic
siderosis.
Only an increased incidence of elderly males and slight evidence of
hepatocellular dysfunction

(fluid retention and jaundice)

clinically dis¬

tinguished the cases with hepatic siderosis.
These observations suggest that the clinico-pathologic syndrome of

V

/
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hemochromatosis blends imperceptibly with that of non-pigmentary portal
cirrhosis.

It seems that portal cirrhosis in some way predisposes to in¬

creased iron absorption and tissue deposition.

Table 1
Pancreatic, and Splenic Iron in

Stainable Hepatic,

Portal Cirrhosis

Liver_Pancreas
Hepatocellular
Iron
None
no liver iron
Kupffer cells only
Slight (1-2+)
Marked (3-4+)
Total

*7o z
**

z

Number of
Cases
35
58%
21
35%
14
23%
18
30%
7
60

12%
100%

advanced
fibrosis
14
9
5
9
5
28

sig.
fat
25
16
9
15
2
42

Percentage of all patients for whom autopsy reports are available.
The 2 cases with pancreatic iron are included in this group.

Mallory
bodies
8
5
3
0
0
8

glycogen
nuclei
2
1
1
3
3
8

sections
available
24
11
13
10
6
40

fibrosis

iron
0

*

+

23
10

1
0

13
6
2
31

4
4
9

42%

8

1

7
1
4
1
13

64%
12%
31%
25%
36%

Spleen
sections
iron
available
si.
0
16
24
5
4
5
10
11
1
14
14
6
44

1
1
7

11
2
29
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1
2
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8
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Possible Clinical Aspects of Hemochromatosis Correlated With Hepa
Pancreatic Stainable Iron in Patients With Portal Cirrhosis

Tissue Iron

No. of
Cases

57 and
below

58 and
above

No hepatocellular iron
no liver iron
without pancreatic iron
with pancreatic iron
Kupffer cell iron only
without pancreatic iron
with pancreatic iron
Slight hepatocellular iron (1-2+)
without pancreatic iron
with pancreatic iron
Marked hepatocellAar iron (3-4+)
without pancreatic iron
with pancreatic iron
Total

One additional chart available.
The denominator = number of men with available charts,
Hct. < 307.

White Women
49 and
50 and
below
above

charts
availab le

excess alco- poor
holic intake diet
26*
15

Personal History
fluid
GI
etention
bleeding

Family History
liver
heart
disease
disease

abnormal
heart

Phy s i ca 1
bronze
pignentation jaundice

Examination ~
fluid
hepato- palpable
spleen retention
megaly
4
4
3
0

testicular atro[hy anemia

11*
10*

7/17
6/11
3/5
0/1
1/6
1/6

17*
5*
4

3/8
1/3
1/3
3/5

5
1
3

1/1
2/3
13/30

laboratory Data~
FBS
>100 mg.7,

glycosuria

Hospital Course
cong.hepaticGi
bleeding
transfused heart fail.

Table 4
Stainable Hepatic,

Type of
Cirrhosis

Post-necrotic

Cardiac

Biliary

Unclassified

Pancreatic, and Splenic Iron in Non-portal Cirrhosis

Tissue
Iron
no liver iron
Kupffer cells only
slight hepatocellular
marked hepatocellular

Pancreatic
Adv.
Iron
Fibrosis
+
3
00
2
0000
4
1
1
1

Splenic
Iron
SS
MM
oos
-

0
0

0
M
M*

-

-

-

2

+

-

-

-

-

0
-

0

S

-

-

no liver iron
Kupffer cells only
slight hepatocellular
marked hepatocellular

5
1
1
0

no liver iron
Kupffer cells only
slight hepatocellular
marked hepatocellular

2
0
1
0

no liver iron
Kupffer cells only
slight hepatocellular
marked hepatocellular

5
1
1
3

2
0
1

00
0

This case also exhibited Kupffer cell iron
S r Slight
M = Marked
*

No. of
Cases
3
2
4
0

+

-

4+

00
M
-
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